By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Roche today announced it has extended its tender offer to acquire all outstanding shares of Illumina.
The offer is now set to expire March 23 at 6 p.m. EST. It had been scheduled to expire at the end of the day Feb. 24.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.
In Science this week: global genetic diversity map, and more.